TGF-BETA-POLYPEPTIDE
European patent · EP4034170 · In force
Register entry
- Publication number
- EP4034170
- Application number
- EP20878575
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 22, 2020
- Published
- Aug 3, 2022
- Granted
- Feb 11, 2026
- Protection ends at the latest
- Oct 21, 2040
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C12N 15/62 (2006.01)C07K 14/71 (2006.01)C07K 14/495 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201962925227 P 23.10.2019
- PCT application
- PCT/US2020/056937 22.10.2020
- PCT publication
- WO2021/081258 29.04.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 13, 2026
Agent entered
- Representative
- Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève
Published in Swissreg on 13.03.2026
- Feb 11, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 11.02.2026
Parties
Inventor
SEIDEL, III, Ronald D.
Cambridge, Massachusetts 02139, US
CHAPARRO, Rodolfo J.
Cambridge, Massachusetts 02139, US
ROSS, John F.
Cambridge, Massachusetts 02139, US
LOW, Chee Meng
Cambridge, Massachusetts 02139, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.